● Recruiting

Finerenone for Patients With Primary Aldosteronism (FAIRY)

Condition: Primary Aldosteronism · Sponsor: Qifu Li

PhasePhase 4

Planned participants306

Who can joinAll sexes, 18 Years to 75 Years

Healthy volunteersNo

About this study

Using spironolactone as the control, to assess the efficacy and safety of finerenone in patients with primary aldosteronism(PA).

This description comes directly from the study's public registry record.

Talk to the study team

Shumin Yang · 02389011552 · 443068494@qq.com

Qifu Li · 02389011552 · liqifu@yeah.net

Always discuss trial participation with your own doctor first.

Locations (1)

the first affiliated hospital of Chongqing medical university

Chongqing, Chongqing Municipality, China

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06457074